Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, November 15, 2016

Public edition | newswise.com

Newswise Cancer Research Wire for 15-Nov-2016
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Photo-Bombing Cancer

Photoimmunotherapy blows up tumors, spares healthy cells By Charles Jolie Nov. 14, 2016 When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she’s describing a Tom Clancy military espio...

– Rush University Medical Center


International Team Decodes Cellular Death Signals

A multidisciplinary international team of scientists solved the mystery of a recently discovered type of controlled cell death, mapping the path to potential therapies for conditions ranging from radiation injury to cancer. The study, led in part by ...

– University of Pittsburgh Medical Center (UPMC)

Nature Chemical Biology

Embargo expired on 14-Nov-2016 at 11:00 ET


New Drug Beats Standard Therapy in Advanced Kidney Cancer

An experimental kidney cancer drug outperformed the standard first-line therapy for patients with metastatic disease who are considered at risk for poorer than average outcomes, according to results of a randomized phase II clinical trial by research...

– Dana-Farber Cancer Institute

Embargo expired on 14-Nov-2016 at 16:00 ET


Long-Sought Genetic Model of Common Infant Leukemia Described

After nearly two decades of unsuccessful attempts, researchers from the University of Chicago and the Cincinnati Children’s Hospital have created the first mouse model for the most common form of infant leukemia. Their model replicates the human ge...

– University of Chicago Medical Center

Cancer Call, Nov. 14, 2016

Embargo expired on 14-Nov-2016 at 12:00 ET


Study: Compound Suggests Chronic Pain Treatment Without Opioid or Medical Marijuana Side Effects

Indiana University neuroscientist Andrea Hohmann took the stage at a press conference Nov. 14 in San Diego to discuss research conducted at IU that has found evidence that the brain’s cannabis receptors may be used to treat chronic pain without the...

– Indiana University

Embargo expired on 14-Nov-2016 at 17:30 ET


Virginal Tech, Cytimmune Sciences Create Cancer Therapy That Reduces Toxic Chemotherapy Effects

Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor. ...

– Virginia Tech


Gene Deletion Allows Cancer Cells to Thrive When Migrating Within the Brain

Astronauts survive in space by wearing high-tech space suits. But how do brain cancer cells thrive when they migrate to inhospitable sites within the brain?...

– University of Texas M. D. Anderson Cancer Center


Mayo Researchers Identify Biomarker to Speed Diagnosis in Brain and Spinal Cord Inflammation

ROCHESTER, Minn. — Research from Mayo Clinic included in the November issue of JAMA Neurology identifies a new biomarker for brain and spinal cord inflammation, allowing for faster diagnosis and treatment of patients....

– Mayo Clinic


First-Line Therapy with Rituximab May Lower Mortality Risk for Rheumatoid Arthritis Patients with Lung Involvement

Patients with rheumatoid arthritis who also have lung involvement often have increased mortality, but first-line therapy with rituximab may help them live longer, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meet...

– American College of Rheumatology (ACR)

2016 ACR/ARHP Annual Meeting

Embargo expired on 12-Nov-2016 at 16:30 ET


Three Gene Sets Could Predict Response to Rheumatoid Arthritis Therapies

Three gene expression signatures can help rheumatologists predict which patients are more likely to respond to tumor necrosis factor inhibitors (TNFi) or B-cell depletion therapies in patients with moderate to severe rheumatoid arthritis....

– American College of Rheumatology (ACR)

2016 ACR/ARHP Annual Meeting

Embargo expired on 12-Nov-2016 at 16:30 ET


Immune Cells May Facilitate Tumor Growth by Forming Primitive Vascular Channels

TSRI Researchers Believe Cell Population May Provide a New Cancer Drug Target...

– Scripps Research Institute


New Discovery Paves Way for Pancreatic Cancer Treatment

November is Pancreatic Cancer Awareness Month. With the discovery that most pancreatic cancer cases are resistant to chemotherapy, researchers at the University of Notre Dame are looking for better ways to treat patients. ...

Expert Available

– University of Notre Dame


Before a Cure, a Crusade to Stop Lung Cancer From Spreading

Researchers from the University of Notre Dame are focused on better understanding lung cancer at a cellular level and investigating drugs that could inhibit lung cancer growth and prevent it from spreading....

Expert Available

– University of Notre Dame


Tiny Barcodes Provide Huge Advance in Personalized Cancer Therapy

Researchers are using synthetic DNA sequences as the tiniest of barcodes to determine which anticancer drugs will work best for each individual patient. It's all done within the patient’s tumor, and before treatment even begins....

– American Technion Society

Nature Communications, Nov 10, 2016


Experimental Drug Delivers One-Two Punch to Prostate Cancer Cells

An experimental drug that targets abnormally high levels of a protein linked to cancer growth appears to significantly reduce the proliferation of prostate cancer cells in laboratory cell cultures and animals, while also making these cells considerab...

– Johns Hopkins Medicine

Cancer Research


Accelerating Cancer Research with Deep Learning

Using the Titan supercomputer at the Oak Ridge Leadership Computing Facility, a DOE Office of Science User Facility located at ORNL, Tourassi’s team applied deep learning to extract useful information from cancer pathology reports, a foundational e...

– Oak Ridge National Laboratory


Ludwig Researchers Show How a Targeted Drug Overcomes Suppressive Immune Cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body’s immune system from attacking tumors. ...

– Ludwig Cancer Research

Nature, Nov-2016


Key Protein in Prostate Cancer Energy Production Identified

Scientists at The Wistar Institute have demonstrated how a protein called TRAP1 – an important regulator of energy production in healthy and cancerous cells – is an important driver of prostate cancer and appears to be a valuable therapeutic targ...

– Wistar Institute

Journal of Biological Chemistry, Oct-2016


Most Indoor Tanning Salons Comply with Texas Tanning Ban for Those Under 18

When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor tanning for those under the age of 18 in a study conducted by The Univ...

– University of Texas M. D. Anderson Cancer Center


Announcements


NCCN Chemotherapy Order Templates to Be Integrated Into Cerner’s Electronic Health Record

Providing access to NCCN Templates® through Cerner’s PowerChart Oncology™ will help practitioners make informed treatment decisions based on up-to-date, standard protocols ...

– National Comprehensive Cancer Network® (NCCN®)


Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation

Henry Ford Health System’s Department of Radiation Oncology has been awarded a three-year term of full accreditation by the American College of Radiology (ACR). ...

– Henry Ford Health System


NYU Langone Melanoma Expert Receives 2016 "Giants of Cancer Care" Award

Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone’s Perlmutter Cancer Center, has received a 2016 “Giants of Cancer Care” Award, presented by OncLive, a professional organization for oncologists....

– NYU Langone Medical Center


AAPS Announces Three Manuscript Awards

The American Association of Pharmaceutical Scientists (AAPS) has selected the award winning manuscripts from three research journals: The AAPS Journal, AAPS PharmSciTech, and Pharmaceutical Research, and. Each of these manuscript awards aim to recogn...

– American Association of Pharmaceutical Scientists (AAPS)

Embargo expired on 13-Nov-2016 at 19:00 ET


Researchers at Children’s Hospital Los Angeles Receive Grant to Study New Way of Battling Resistant Cancer Cells

Yong-Mi Kim, MD, PhD, of Children’s Hospital Los Angeles, has been awarded a 3 year translational research program grant from the Leukemia & Lymphoma Society to study a novel approach to eradicating minimal residual disease in patients with acute l...

– Children's Hospital Los Angeles Saban Research Institute


Seattle Cancer Care Alliance and Hawaii Pacific Health Announce Partnership to Expand Access for Patients in Hawaii

Hawaii Pacific Health has joined the Seattle Cancer Care Alliance Affiliate Network. SCCA has 13 Affiliate Network partners located across the Western U.S., including in Alaska, Idaho, Montana, Oregon, Washington, and now Hawaii. ...

– Seattle Cancer Care Alliance

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

  Newswise

 Oak Ridge National Laboratory

 University of Texas M. D. Anderson Cancer Center

 University of Pittsburgh Medical Center (UPMC)

 University of Notre Dame

 Seattle Cancer Care Alliance


Subscribe / Unsubscribe
Edit my preferences

© 2016 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us